Shorepoint Capital Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.12M | Buy |
70,663
+1,001
| +1% | +$72.6K | 1.16% | 30 |
|
|
2024
Q4 | $5.16M | Buy |
69,662
+1,737
| +3% | +$129K | 1.18% | 28 |
|
|
2024
Q3 | $4.48M | Buy |
67,925
+1,701
| +3% | +$112K | 1.02% | 37 |
|
|
2024
Q2 | $6.12M | Buy |
66,224
+2,149
| +3% | +$199K | 1.44% | 23 |
|
|
2024
Q1 | $6.12M | Sell |
64,075
-977
| -2% | -$93.4K | 1.5% | 23 |
|
|
2023
Q4 | $4.96M | Sell |
65,052
-2,704
| -4% | -$206K | 1.33% | 28 |
|
|
2023
Q3 | $4.69M | Sell |
67,756
-3,782
| -5% | -$262K | 1.38% | 26 |
|
|
2023
Q2 | $6.75M | Buy |
71,538
+438
| +0.6% | +$41.3K | 1.9% | 15 |
|
|
2023
Q1 | $5.88M | Buy |
71,100
+5,675
| +9% | +$469K | 1.68% | 17 |
|
|
2022
Q4 | $4.88M | Buy |
+65,425
| New | +$4.88M | 1.36% | 23 |
|